MedPath
NMPA Approval

复方金黄连颗粒

国药准字Z20070040

February 15, 2022

国药准字Z20070040

Drug Information

复方金黄连颗粒

颗粒剂

每袋装8g(无蔗糖)

中药

February 15, 2022

Company Information

Applicant Company

北京市大兴区中关村科技园区生物医药产业基地永大西路37号

Manufacturing Company

河北省沙河市栾卸工业区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方金黄连颗粒 - NMPA 批准文号 | MedPath